La cadena de opciones muestra datos clave de las opciones de acciones de 9F a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para 9F..

9F (NASDAQ:JFU) Bolsa, Cadena de Opciones

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.

9F Inc

In a call hosted today, June 9, 2025, PolyPid Ltd. unveiled highly successful topline results from its SHIELD II Phase 3 trial of D-PLEX100 for preventing surgical site infections (SSIs) in abdominal colorectal surgery patients with large incisions.
The double-blind trial of 798 patients achieved statistical significance across all endpoints, demonstrating a 38% reduction in the primary composite endpoint and a remarkable 58% reduction in SSI rates from 9.5% to 3.8% compared to standard care alone.
These results position D-PLEX100 among the most effective prophylactic interventions for this indication, addressing a significant unmet medical need that costs the U.S. healthcare system up to $10 billion annually.
With FDA Fast Track, Breakthrough Therapy, and QIDP designations already secured, PolyPid plans a pre-NDA meeting by end-2025 followed by NDA submission in early 2026, while these compelling Phase 3 results are expected to accelerate ongoing global partnership discussions for commercialization.

News

PYPD

Polypid Announces Results From SHIELD II Phase 3 Trial Of D-PLEX100 For Preventing SSIs In Abdominal Colorectal Surgery Patients With Large Incisions

WIIM

VinFast Auto shares are trading higher after the company reported better-than-expected Q1 sales results and a year-over-year increase in Q1 EV and E-scooter deliveries.

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

NKTR

AEMD

Barclays analyst Brandon Oglenski initiates coverage on Landstar System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTR#NASDAQ">LSTR</a>) with a Equal-Weight rating and announces Price Target of $145.

Price Target

Initiation

Analyst Ratings

LSTR

Barclays Initiates Coverage On Landstar System with Equal-Weight Rating, Announces Price Target of $145

Barclays analyst Brian Morton downgrades Bank of Montreal (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BMO#TSX">BMO</a>) from Overweight to Equal-Weight and announces C$144 price target.

Downgrades

TSX:BMO

Barclays Downgrades Bank of Montreal to Equal-Weight, Announces C$144 Price Target

IONQ

IonQ shares are trading higher after the company announced results of a collaborative research program with AstraZeneca, Amazon Web Services and NVIDIA to develop and demonstrate a quantum-accelerated computational chemistry workflow.

Jefferies analyst Xiaoyi Lei initiates coverage on Hesai Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) with a Buy rating and announces Price Target of $29.3.

HSAI

Jefferies Initiates Coverage On Hesai Gr with Buy Rating, Announces Price Target of $29.3

On June 9, 2025, Strategy announced updates with respect to its bitcoin holdings:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td colspan="7">&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="7">&nbsp;</td>
</tr>
<tr>
<td>&nbsp;</td>
<td colspan="7">During Period June 2, 2025 to June 8, 2025</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="7">As of June 8, 2025</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>
BTC
Acquired&nbsp;(1)
</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>
Aggregate
Purchase
Price (in millions)&nbsp;(2)
</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>
Average
Purchase
Price&nbsp;(2)
</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>
Aggregate
BTC
Holdings
</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>
Aggregate
Purchase
Price (in millions)&nbsp;(2)
</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>
Average
Purchase
Price&nbsp;(2)
</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>1,045</td>
<td>&nbsp;</td>
<td>$</td>
<td>110.2</td>
<td>&nbsp;</td>
<td>$</td>
<td>105,426</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>582,000</td>
<td>&nbsp;</td>
<td>$</td>
<td>40,790.4</td>
<td>&nbsp;</td>
<td>$</td>
<td>70,086</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;
(1) The bitcoin purchases were made using proceeds from the STRK ATM and STRF ATM.
&nbsp;
(2) Aggregate and average purchase prices are inclusive of fees and expenses.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

MSTR

Strategy Acquires 1,045 BTC For $110.2M Between June 2-June 8

Jefferies analyst Laurence Alexander upgrades Quaker Houghton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWR#NYSE">KWR</a>) from Hold to Buy and raises the price target from $115 to $146.

Upgrades

Jefferies Upgrades Quaker Houghton to Buy, Raises Price Target to $146

NAMS

NewAmsterdam Pharma shares are trading higher after the company announced topline data from prespecified Alzheimer's Disease biomarker analyses in the Phase 3 BROADWAY clinical trial

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) V-shaped recovery has surprised traders, but according to a prominent analyst, the $106,800 resistance level, a barrier BTC has failed to overcome for nearly seven months, remains the <a href="https://www.benzinga.com/money/bitcoin-price-prediction">line in the sand</a>.
What Happened: Crypto analyst Kevin believes Bitcoin&#8217;s recent rebound has caught traders off guard, but warns the cryptocurrency faces a make-or-break moment at this level, which has repeatedly rejected Bitcoin&#8217;s attempts to establish higher ground throughout 2025.
In the latest update in his <a href="https://www.patreon.com/c/KevCapitalTA/posts">exclusive Patreon group</a>, Kevin noted that despite a sharp 5.5% rebound from local lows, he's seeing mixed signals. 
"The 4-hour market cypher shows some increasing money flow," he wrote, "but it's still in the negative. We need more confirmation."
More importantly, the whale money flow indicator has entered its upper range — a zone that "usually precedes distribution." In simpler terms: big holders might be getting ready to sell.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45833498/bitcoin-ethereum-xrp-dogecoin-start-the-week-green-ahead-of-us-china-trade-talks">Bitcoin, Ethereum, XRP, Dogecoin Start The Week Green Ahead Of US-China Trade Talks</a>
Why It Matters: Kevin emphasized that time is now a critical factor. "If we don't break this resistance soon, buyers will lose steam," he warned. "Liquidity is thin, and repeated rejections will likely drag us back to lower levels."
He pointed to two macro bullish indicators still in play:
<ul class="wp-block-list">
<li>A weekly hash ribbons buy signal triggered three weeks ago.</li>
<li>A perfect 5-year correlation with global liquidity trends that still supports upside.</li>
</ul>
But he remains cautious. "You can have every bullish indicator flashing green, but without money flow, price action stalls," Kevin noted.
What's Next: The $100,000–$103,000 range remains Bitcoin's last line of defense. 
A breakdown below it could open the door to a prolonged correction as bullish momentum fades. 
Kevin summed up his strategy: "We'll continue to treat resistance as resistance — until it isn't. Stay smart, stay unbiased, and always be prepared for both outcomes."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45797385/bitcoin-becomes-corporate-treasury-favorite-eth-sol-xrp-far-behind-report">Bitcoin Becomes Corporate Treasury Favorite, ETH, SOL, XRP Far Behind: Report</a></li>
</ul>
Image: Shutterstock

$BTC

Bitcoin Pushes To $107,000 As Pivotal Resistance Level Gets Tested Once Again

Jefferies analyst Daniel Fannon initiates coverage on Etoro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETOR#NASDAQ">ETOR</a>) with a Buy rating and announces Price Target of $80.

ETOR

Jefferies Initiates Coverage On Etoro Group with Buy Rating, Announces Price Target of $80

Cantor Fitzgerald analyst Brett Knoblauch initiates coverage on Etoro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETOR#NASDAQ">ETOR</a>) with a Overweight rating and announces Price Target of $84.

Cantor Fitzgerald Initiates Coverage On Etoro Group with Overweight Rating, Announces Price Target of $84

CRANFORD, N.J., June 9, 2025 /PRNewswire/ --&nbsp;Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it has entered into a distribution services agreement with Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>), a leading provider of pharmaceutical and specialty pharmaceutical distribution services in the United States.
This agreement is designed to help provide access to LYMPHIR&#x2122; (denileukin diftitox-cxdl), an innovative immunotherapy FDA-approved for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma (CTCL), in support of its anticipated U.S. commercial launch.

CTOR

CTXR

Citius Pharma's Subsidiary Citius Oncology Enters Into Distribution Services Agreement With Cardinal Health; Deal Supports Upcoming Launch Of LYMPHIR For Treatment Of Cutaneous T-Cell Lymphoma

Shares of Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) rose sharply in today's pre-market trading on continued <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45821941/circle-crcl-stock-surges-after-successful-ipo-debut-whats-going-on">IPO launch strength</a>.
Circle Internet Group, the issuer of the USDC stablecoin, made a powerful public debut last week, with shares surging more than 29% on Friday following Thursday&#8217;s IPO. The stock opened at $69, more than double its $31 IPO price, giving the company an initial valuation of $6.9 billion.
Circle Internet Group shares jumped 18.1% to $126.99 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Klotho Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) shares jumped 123.5% to $0.4582 in pre-market trading after the company said gene therapy boosted lifespan by 20% in mice, eyes anti-aging breakthrough.</li>
<li>Know Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNW#NYSE">KNW</a>) surged 110.9% to $3.29 in pre-market trading. Know Labs shares jumped 205% on Friday after the company announced that entered into an agreement to be acquired by Goldeneye 1995. Also, the company announced a Bitcoin treasury strategy.</li>
<li>Ohmyhome Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMH#NASDAQ">OMH</a>) jumped 59.4% to $0.9627 in pre-market trading after dipping 43% on Friday. Ohmyhome, on May 21, announced a registered direct offering of 4.04 million ordinary shares at $0.45 per share.</li>
<li>PMGC Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) climbed 55.8% to $3.38 in pre-market trading as the company signed a Letter of Intent to acquire a profitable U.S.-based electronics manufacturing company.</li>
<li>Tempest Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) surged 32.2% to $10.90 in pre-market trading. Tempest Therapeutics, last week, announced it received orphan drug designation from the EMA for its amezalpat for the treatment of patients with hepatocellular carcinoma</li>
<li>Northann Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCL#NYSE">NCL</a>) gained 31.5% to $0.3123 in pre-market trading after dipping more than 80% on Friday. The company recently announced that it is not aware of any new material developments or pending announcements concerning its business operations that may be contributing to the recent volatile market activity.</li>
<li>PolyPid Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPD#NASDAQ">PYPD</a>) rose 23.5% to $4.0401 in pre-market trading after the company disclosed positive topline results from its pivotal SHIELD II Phase 3 trial of D-PLEX100 for the prevention of SSIs in patients undergoing abdominal colorectal surgery with large incisions, which has received Fast Track designation from the FDA.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) rose 17.8% to $32.38 in pre-market trading after the company announced positive Phase 1 data of first-in-class once-monthly amylin candidate MET-233i.</li>
<li>Graham Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHM#NYSE">GHM</a>) gained 17.7% to $49.44 in pre-market trading following better-than-expected fourth-quarter results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) shares tumbled 27% to $0.1586 in pre-market trading after gaining 8% on Friday.</li>
<li>The Children&#8217;s Place, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) dipped 24.1% to $ 5.21 in pre-market trading as the company posted weaker-than-expected results for its first quarter after the closing bell on Friday.</li>
<li>Namib Minerals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMM#NASDAQ">NAMM</a>) shares fell 19.9% to $25.00 in pre-market trading after jumping 82% on Friday.</li>
<li>Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) declined 14.8% to $0.4950 in pre-market trading. Silo Pharma's recently board approved the purchase of up to $1 million in Bitcoin as a treasury reserve asset.</li>
<li>Helius Medical Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) declined 14.7% to $0.9300 in pre-market trading. Helius Medical Technologies, last week, announced a $9.1 million public offering.</li>
<li>Davis Commodities Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTCK#NASDAQ">DTCK</a>) dipped 14.2% to $0.69 in pre-market trading after jumping 34% on Friday.</li>
<li>Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) fell 12.9% to $0.5922 in pre-market trading. Opendoor Technologies filed preliminary proxy for July 28 special meeting seeking shareholder approval for reverse stock split at ratio between 1-for-10 and 1-for-50.</li>
<li>VirnetX Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VHC#NYSE">VHC</a>) fell 11.8% to $10.00 in pre-market trading after jumping over 15% on Friday.</li>
<li>EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) fell 10% to $15.74 in pre-market trading after dipping 8% on Friday.</li>
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) declined 7% to $22.55 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45811726/cramer-says-hes-not-going-to-really-want-to-do-a-lot-of-china-right-now">Cramer Says He&#8217;s &#8216;Not Going To Really Want To Do A Lot Of China Right Now&#8217;</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Movers

Trading Ideas

CRCL

DTCK

ELAB

HSDT

KLTO

LIMN

MTSR

NAMM

Nuveen Insured California Premium Fund Ii

NOVA

OPEN

PLCE

SATS

SILO

Tempest Therapeutics, Inc. - Common Stock

TPST

Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Cantor Fitzgerald analyst Yi Fu Lee initiates coverage on Docebo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) with a Overweight rating and announces Price Target of $35.

DCBO

Cantor Fitzgerald Initiates Coverage On Docebo with Overweight Rating, Announces Price Target of $35

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">PTL Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTLE#NASDAQ">PTLE</a>)</h3>
<ul class="wp-block-list">
<li>On April 9, PTL Limited priced its $7.14 million public offering of 23.8 million ordinary shares at $0.30 per share. The company's stock fell around 80% over the past five days and has a 52-week low of $0.27.</li>
<li>RSI Value: 20.8</li>
<li>PTLE Price Action: Shares of PTL fell 8.4% to close at $0.28 on Friday.</li>
<li>Edge Stock Ratings: Value at 46.61.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/PTLE"><img loading="lazy" decoding="async" width="410" height="177" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09083837/image-111.png" alt="" class="wp-image-943132" style="width:306px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09083837/image-111.png 410w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09083837/image-111-300x130.png 300w" sizes="(max-width: 410px) 100vw, 410px" /></a></figure>
<h3 class="wp-block-heading">Houston American Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUSA#NYSE">HUSA</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On May 28, Houston American Energy announced a 1-for-10 reverse stock split. The company's stock fell around 10% over the past month and has a 52-week low of $0.39.</li>
<li>RSI Value: 17.3</li>
<li>HUSA Price Action: Shares of Houston American Energy gained 1.6% to close at $0.4878 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in HUSA stock. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0609"><img loading="lazy" decoding="async" width="908" height="802" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09083948/image-112.png" alt="" class="wp-image-943136" style="width:659px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09083948/image-112.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09083948/image-112-300x265.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09083948/image-112-768x678.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45811726/cramer-says-hes-not-going-to-really-want-to-do-a-lot-of-china-right-now">Cramer Says He&#8217;s &#8216;Not Going To Really Want To Do A Lot Of China Right Now&#8217;</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

HUSA

PTLE

Top 2 Energy Stocks That May Rocket Higher This Quarter

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) is breaking out and <a href="https://www.benzinga.com/quote/RDDT">added that it is a &#8220;winner.&#8221;</a>
As per the recent news, Reddit, on June 4, filed a lawsuit against artificial intelligence startup Anthropic, accusing it of unauthorized use of Reddit&#8217;s data for AI model training.
&#8220;I want you to stay in it. If anything, I'd like you to buy more,&#8221; Cramer said when asked about Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>). &#8220;We don't care where a stock came from, we care where it's going to. I think it's going higher.&#8221;
Disney is reportedly cutting hundreds of roles. According to <a href="https://variety.com/2025/tv/news/disney-mass-layoffs-tv-film-finance-departments-1236415786/">Variety</a>, the cuts span multiple departments, including film and television marketing, publicity, casting, development, and corporate finance.
Kinder Morgan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) is &#8220;good,&#8221; Cramer said.
Lending support to his choice, Scotiabank analyst Brandon Bingham, on June 5, raised the price target on the stock from $26 to $27.
Cramer said although he likes the subscription businesses of Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>), but doesn't think they have the growth. Therefore, he recommends Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) in case of going with a subscription business.
On June 3, a report suggested the company is launching a resale market for used bikes and treadmills.
Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) is &#8220;gaining momentum, it'll burst through,&#8221; Cramer said.
Supporting his view, the company, on May 15, posted better-than-expected quarterly earnings.
Price Action:
<ul class="wp-block-list">
<li>Disney shares gained 1.2% to settle at $113.90 on Friday.</li>
<li>Peloton gained 5.2% to settle at $7.30 on Friday.</li>
<li>Walmart shares fell 0.5% to close at $97.47.</li>
<li>Kinder Morgan shares fell 0.4% to settle at $28.14 on Friday.</li>
<li>Reddit shares climbed 8.1% to settle at $121.29 during the session.</li>
</ul>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45811726/cramer-says-hes-not-going-to-really-want-to-do-a-lot-of-china-right-now">Cramer Says He&#8217;s &#8216;Not Going To Really Want To Do A Lot Of China Right Now&#8217;</a></li>
</ul>
Image: Shutterstock

Media

PTON

RDDT

SPOT

Jim Cramer Says Kinder Morgan Is 'Good,' Calls This Communication Services Stock A 'Winner'

Press Releases

Cango Inc. Announces Closing of PRC Business Disposal and Certain Changes to Board of Directors and Senior Management

Fintech

9F Inc. Announces Receipt of Nasdaq Notification Regarding Late Filing of Form 20-F

CANG

Antelope Enterprise Holdings Limited - Class A Ordinary Shares

Antelope Ent Hldgs

BuzzFeed

Cheer Holding, Inc. - Class A Ordinary Share

Cheer Holding

DHI Group

Phoenix New Media Limited American Depositary Shares, each representing 48 Class A ordinary shares.

Comments

9F

9F (JFU) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL